BJDX — Bluejay Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- $2.87m
- -$1.42m
Annual cashflow statement for Bluejay Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.16 | -3.49 | -9.3 | -9.95 | -7.72 |
| Depreciation | |||||
| Non-Cash Items | -0.104 | 0.461 | 0.67 | 0.192 | 0.332 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.596 | -1.49 | 0.579 | 0.667 | -0.633 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.509 | -4.37 | -7.74 | -8.31 | -7.82 |
| Capital Expenditures | 0 | -0.024 | -1.2 | -0.704 | -0.307 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.024 | -1.2 | -0.704 | -0.307 |
| Financing Cash Flow Items | 0 | -0.563 | -0.02 | -0.474 | -1.84 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.33 | 22.5 | 0.008 | 1.11 | 10.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.816 | 18.1 | -8.93 | -7.91 | 2.09 |